Home/Filings/4/0001477449-24-000040
4//SEC Filing

Trencher Daniel 4

Accession 0001477449-24-000040

CIK 0001477449other

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 4:08 PM ET

Size

29.2 KB

Accession

0001477449-24-000040

Insider Transaction Report

Form 4
Period: 2024-03-01
Trencher Daniel
SVP Corporate Strategy
Transactions
  • Exercise/Conversion

    Common Stock

    2024-03-01+3,80320,591 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-03-0111,16022,322 total
    Common Stock (11,160 underlying)
  • Exercise/Conversion

    Common Stock

    2024-03-01+36420,955 total
  • Exercise/Conversion

    Common Stock

    2024-03-01+72221,677 total
  • Exercise/Conversion

    Common Stock

    2024-03-01+1,17922,856 total
  • Exercise/Conversion

    Common Stock

    2024-03-01+11,16034,016 total
  • Exercise/Conversion

    Common Stock

    2024-03-01+95634,972 total
  • Sale

    Common Stock

    2024-03-04$14.52/sh6,780$98,41828,192 total
  • Award

    Performance Stock Units

    2024-03-01+11,41111,411 total
    Common Stock (11,411 underlying)
  • Exercise/Conversion

    Performance Stock Units

    2024-03-013,8037,608 total
    Common Stock (3,803 underlying)
  • Exercise/Conversion

    Performance Stock Units

    2024-03-013640 total
    Common Stock (364 underlying)
  • Exercise/Conversion

    Performance Stock Units

    2024-03-017220 total
    Common Stock (722 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2024-03-011,1794,717 total
    Common Stock (1,179 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2024-03-019560 total
    Common Stock (956 underlying)
Footnotes (12)
  • [F1]Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
  • [F10]On March 1, 2022, the reporting person was granted 14,149 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  • [F11]On March 3, 2023, the reporting person was granted 33,482 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  • [F12]On March 2, 2021, the reporting person was granted 2,868 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
  • [F2]Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
  • [F3]Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
  • [F4]Each performance stock unit represents a contingent right to receive one share of TDOC common stock.
  • [F5]Performance award amount determined based on metrics in respect of the issuer's 2023 financial results.
  • [F6]The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  • [F7]On March 1, 2024, the reporting person earned 11,411 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  • [F8]On March 2, 2023, the reporting person earned 729 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2023.
  • [F9]On March 2, 2022, the reporting person earned 2,168 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022.

Issuer

Teladoc Health, Inc.

CIK 0001477449

Entity typeother

Related Parties

1
  • filerCIK 0001830122

Filing Metadata

Form type
4
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:08 PM ET
Size
29.2 KB